Article info

Download PDFPDF

Changes in ocular signs and symptoms in patients switching from bimatoprost–timolol to tafluprost–timolol eye drops: an open-label phase IV study

Authors

  1. Correspondence to Professor Rupert Richard Alexander Bourne; rb{at}rupertbourne.co.uk
View Full Text

Citation

Bourne RRA, Kaarniranta K, Lorenz K, et al
Changes in ocular signs and symptoms in patients switching from bimatoprost–timolol to tafluprost–timolol eye drops: an open-label phase IV study

Publication history

  • Received May 10, 2018
  • Revised December 6, 2018
  • Accepted February 11, 2019
  • First published April 2, 2019.
Online issue publication 
February 15, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.